Related Experiment Video
Updated: Aug 1, 2026

A Mouse Model of Lumbar Spine Instability
Published on: April 23, 2021
p300 arrests intervertebral disc degeneration by regulating the FOXO3/Sirt1/Wnt/β-catenin axis
Yingjie Hao1, Zhinan Ren1, Lei Yu1
1Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
The transcription factor p300 is reportedly involved in age-associated human diseases, including intervertebral disc degeneration (IDD). In this study, we investigate the potential role and pathophysiological mechanism of p300 in IDD. Clinical tissue samples were collected from patients with lumbar disc herniation (LDH), in which the expression of p300, forkhead box O3 (FOXO3), and sirtuin 1 (Sirt1) was determined. Nucleus pulposus cells (NPCs) isolated from clinical degenerative intervertebral disc (IVD) tissues were introduced with oe-p300, oe-FOXO3, Wnt/β-catenin agonist 1, C646 (p300/CBP inhibitor), or si-p300 to explore the functional role of p300 in IDD and to characterize the relationship between p300 and the FOXO3/Sirt1/Wnt/β-catenin pathway. Also, we established a rat IDD model by inducing needle puncture injuries in the caudal IVDs for further verification of p300 functional role. We found that p300 was downregulated in the clinical tissues and NPCs of IDD. Overexpression of p300 promoted the proliferation and autophagy of NPCs while inhibiting cell apoptosis, which was associated with FOXO3 upregulation. p300 could increase the expression of FOXO3 by binding to the Sirt1 promoter, and thus, contributed to inactivation of the Wnt/β-catenin pathway. In vivo results further displayed that p300 slowed down the progression of IDD by disrupting the Wnt/β-catenin pathway through the FOXO3/Sirt1 axis. Taken together, we suggest that p300 can act to suppress IDD via a FOXO3-dependent mechanism, highlighting a potential novel target for treatment of IDD.
Insights
The transcription factor p300 suppresses intervertebral disc degeneration (IDD) by upregulating FOXO3, which inactivates the Wnt/β-catenin pathway. This finding highlights p300 as a potential therapeutic target for IDD.
Area of Science:
- Biochemistry
- Molecular Biology
- Regenerative Medicine
Background:
- The transcription factor p300 is implicated in age-related diseases, including intervertebral disc degeneration (IDD).
- Understanding the role of p300 in IDD pathogenesis is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role and underlying mechanisms of p300 in IDD.
- To explore the relationship between p300, FOXO3, Sirt1, and the Wnt/β-catenin pathway in IDD.
Main Methods:
- Analysis of p300, FOXO3, and Sirt1 expression in human IDD tissues and nucleus pulposus cells (NPCs).
- In vitro experiments using NPCs with manipulated p300 and FOXO3 levels, and Wnt/β-catenin pathway modulators.
- Establishment and analysis of a rat IDD model to validate in vivo findings.
Main Results:
- p300 expression was decreased in IDD tissues and NPCs.
- Overexpression of p300 enhanced NPC proliferation and autophagy, inhibited apoptosis, and upregulated FOXO3.
- p300 increased FOXO3 expression by targeting the Sirt1 promoter, leading to Wnt/β-catenin pathway inactivation.
- In vivo, p300 mitigated IDD progression by inhibiting the Wnt/β-catenin pathway via the FOXO3/Sirt1 axis.
Conclusions:
- p300 acts as a suppressor of IDD through a FOXO3-dependent mechanism.
- The p300/FOXO3/Sirt1/Wnt/β-catenin axis represents a potential therapeutic strategy for IDD.
More Related Videos
Related Concept Videos
Degenerative Disc Disease I: Introduction
Degenerative Disc Disease ll: Pathophysiology

